Relationship of p220 cleavage during picornavirus infection to 2A proteinase sequencing.

PubWeight™: 2.32‹?› | Rank: Top 2%

🔗 View Article (PMC 253854)

Published in J Virol on November 01, 1988

Authors

R E Lloyd1, M J Grubman, E Ehrenfeld

Author Affiliations

1: Department of Cellular, Viral and Molecular Biology, University of Utah School of Medicine, Salt Lake City 84132.

Articles citing this

RNA-protein interactions in regulation of picornavirus RNA translation. Microbiol Rev (1996) 3.36

Expression of virus-encoded proteinases: functional and structural similarities with cellular enzymes. Microbiol Rev (1993) 3.33

Leader protein of foot-and-mouth disease virus is required for cleavage of the p220 component of the cap-binding protein complex. J Virol (1988) 3.28

Cleavage of poly(A)-binding protein by enterovirus proteases concurrent with inhibition of translation in vitro. J Virol (1999) 2.70

Internal entry of ribosomes is directed by the 5' noncoding region of classical swine fever virus and is dependent on the presence of an RNA pseudoknot upstream of the initiation codon. J Virol (1997) 2.55

A region of the 5' noncoding region of foot-and-mouth disease virus RNA directs efficient internal initiation of protein synthesis within cells: involvement with the role of L protease in translational control. J Virol (1990) 2.45

Foot-and-mouth disease virus leader proteinase: purification of the Lb form and determination of its cleavage site on eIF-4 gamma. J Virol (1994) 2.41

The eIF4G-eIF4E complex is the target for direct cleavage by the rhinovirus 2A proteinase. J Virol (1996) 2.21

Low efficiency of the 5' nontranslated region of hepatitis A virus RNA in directing cap-independent translation in permissive monkey kidney cells. J Virol (1994) 2.00

Replication of poliovirus RNA and subgenomic RNA transcripts in transfected cells. J Virol (1992) 1.88

Cleavage of poly(A)-binding protein by poliovirus 3C protease inhibits host cell translation: a novel mechanism for host translation shutoff. Mol Cell Biol (2004) 1.84

Eukaryotic initiation factor 4GII (eIF4GII), but not eIF4GI, cleavage correlates with inhibition of host cell protein synthesis after human rhinovirus infection. J Virol (1999) 1.72

Proteolytic cleavage of initiation factor eIF-4 gamma in the reticulocyte lysate inhibits translation of capped mRNAs but enhances that of uncapped mRNAs. Nucleic Acids Res (1995) 1.72

Polyprotein processing of Theiler's murine encephalomyelitis virus. J Virol (1989) 1.64

Efficient cleavage of ribosome-associated poly(A)-binding protein by enterovirus 3C protease. J Virol (2002) 1.59

Papain-like protease p29 as a symptom determinant encoded by a hypovirulence-associated virus of the chestnut blight fungus. J Virol (1993) 1.59

Eukaryotic initiation factor 3 is required for poliovirus 2A protease-induced cleavage of the p220 component of eukaryotic initiation factor 4F. Proc Natl Acad Sci U S A (1990) 1.58

Echovirus 22 is an atypical enterovirus. J Virol (1990) 1.55

Foot-and-mouth disease virus protease 3C induces specific proteolytic cleavage of host cell histone H3. J Virol (1990) 1.54

Protein 2A is not required for Theiler's virus replication. J Virol (1997) 1.51

Characterization of poliovirus 2A proteinase by mutational analysis: residues required for autocatalytic activity are essential for induction of cleavage of eukaryotic initiation factor 4F polypeptide p220. J Virol (1991) 1.51

A single nucleotide substitution in the internal ribosome entry site of foot-and-mouth disease virus leads to enhanced cap-independent translation in vivo. J Virol (1993) 1.50

Effects of mutations in poliovirus 3Dpol on RNA polymerase activity and on polyprotein cleavage. J Virol (1989) 1.48

Foot-and-mouth disease virus Lb proteinase can stimulate rhinovirus and enterovirus IRES-driven translation and cleave several proteins of cellular and viral origin. J Virol (1995) 1.48

Calicivirus 3C-like proteinase inhibits cellular translation by cleavage of poly(A)-binding protein. J Virol (2004) 1.44

Antiviral effects of a thiol protease inhibitor on foot-and-mouth disease virus. J Virol (1992) 1.29

Determinants of substrate recognition by poliovirus 2A proteinase. J Virol (1992) 1.29

Relationship of eukaryotic initiation factor 3 to poliovirus-induced p220 cleavage activity. J Virol (1992) 1.25

Processing of a cellular polypeptide by 3CD proteinase is required for poliovirus ribonucleoprotein complex formation. J Virol (1997) 1.21

Cleavage of eukaryotic translation initiation factor 4GII within foot-and-mouth disease virus-infected cells: identification of the L-protease cleavage site in vitro. J Virol (2004) 1.15

Foot-and-mouth disease virus 3C protease induces cleavage of translation initiation factors eIF4A and eIF4G within infected cells. J Virol (2000) 1.15

Rapamycin and wortmannin enhance replication of a defective encephalomyocarditis virus. J Virol (1998) 1.13

Different effect of proteasome inhibition on vesicular stomatitis virus and poliovirus replication. PLoS One (2008) 1.10

A poliovirus minireplicon containing an inactive 2A proteinase is expressed in vaccinia virus-infected cells. J Virol (1993) 1.07

Functional analysis of the two alternative translation initiation sites of foot-and-mouth disease virus. J Virol (1995) 1.07

Defective RNA replication by poliovirus mutants deficient in 2A protease cleavage activity. J Virol (1995) 1.05

The multifaceted poliovirus 2A protease: regulation of gene expression by picornavirus proteases. J Biomed Biotechnol (2011) 1.05

Analysis of picornavirus 2A(pro) proteins: separation of proteinase from translation and replication functions. J Virol (1995) 1.01

Increased long chain acyl-Coa synthetase activity and fatty acid import is linked to membrane synthesis for development of picornavirus replication organelles. PLoS Pathog (2013) 0.98

A stable HeLa cell line that inducibly expresses poliovirus 2A(pro): effects on cellular and viral gene expression. J Virol (2000) 0.98

Competitive translation efficiency at the picornavirus type 1 internal ribosome entry site facilitated by viral cis and trans factors. J Virol (2006) 0.97

Regulation of poliovirus 3C protease by the 2C polypeptide. J Virol (2004) 0.91

Hepatitis A viruses with deletions in the 2A gene are infectious in cultured cells and marmosets. J Virol (1995) 0.91

cis- and trans-cleavage activities of poliovirus 2A protease expressed in Escherichia coli. J Virol (1991) 0.90

The processing of eIF4GI by human rhinovirus type 2 2A(pro): relationship to self-cleavage and role of zinc. J Virol (2003) 0.90

Mapping the genetic determinants of pathogenicity and plaque phenotype in swine vesicular disease virus. J Virol (1999) 0.90

Replication and Inhibitors of Enteroviruses and Parechoviruses. Viruses (2015) 0.89

Mutational analysis of the EMCV 2A protein identifies a nuclear localization signal and an eIF4E binding site. Virology (2010) 0.83

Encapsidation and serial passage of a poliovirus replicon which expresses an inactive 2A proteinase. J Virol (1995) 0.83

Conformational plasticity of the 2A proteinase from enterovirus 71. J Virol (2013) 0.82

The outcome of poliovirus infections in K562 cells is cytolytic rather than persistent after hemin-induced differentiation. J Virol (1996) 0.81

Multiple Poliovirus Proteins Repress Cytoplasmic RNA Granules. Viruses (2015) 0.80

Viruses and viral proteins. IUCrJ (2014) 0.78

Innate Immunity Evasion by Enteroviruses: Insights into Virus-Host Interaction. Viruses (2016) 0.77

Structures and Corresponding Functions of Five Types of Picornaviral 2A Proteins. Front Microbiol (2017) 0.75

Articles cited by this

An efficient mRNA-dependent translation system from reticulocyte lysates. Eur J Biochem (1976) 46.42

Inhibition of HeLa cell protein synthesis following poliovirus infection correlates with the proteolysis of a 220,000-dalton polypeptide associated with eucaryotic initiation factor 3 and a cap binding protein complex. J Biol Chem (1982) 7.82

A second virus-encoded proteinase involved in proteolytic processing of poliovirus polyprotein. Cell (1986) 5.53

Proteolytic processing of poliovirus polypeptides: antibodies to polypeptide P3-7c inhibit cleavage at glutamine-glycine pairs. Proc Natl Acad Sci U S A (1982) 5.50

The nucleotide and deduced amino acid sequences of the encephalomyocarditis viral polyprotein coding region. Nucleic Acids Res (1984) 4.95

Poliovirus mutant that does not selectively inhibit host cell protein synthesis. Mol Cell Biol (1985) 4.94

In vitro translation of poliovirus RNA: utilization of internal initiation sites in reticulocyte lysate. J Virol (1984) 4.54

Poliovirus proteinase 2A induces cleavage of eucaryotic initiation factor 4F polypeptide p220. J Virol (1987) 4.52

Complete nucleotide sequence of wild-type hepatitis A virus: comparison with different strains of hepatitis A virus and other picornaviruses. J Virol (1987) 4.49

Regulation of translation by poliovirus. Adv Virus Res (1987) 4.08

Analysis of the complete nucleotide sequence of the picornavirus Theiler's murine encephalomyelitis virus indicates that it is closely related to cardioviruses. J Virol (1987) 3.77

Identification of the initiation site of poliovirus polyprotein synthesis. J Virol (1982) 3.62

Leader protein of foot-and-mouth disease virus is required for cleavage of the p220 component of the cap-binding protein complex. J Virol (1988) 3.28

Molecular cloning and complete sequence determination of RNA genome of human rhinovirus type 14. Proc Natl Acad Sci U S A (1985) 3.17

Similarity in gene organization and homology between proteins of animal picornaviruses and a plant comovirus suggest common ancestry of these virus families. Nucleic Acids Res (1984) 2.99

Impact of virus infection on host cell protein synthesis. Annu Rev Biochem (1987) 2.98

Genome of coxsackievirus B3. Virology (1987) 2.88

A second protease of foot-and-mouth disease virus. J Virol (1986) 2.87

In vitro molecular genetics as a tool for determining the differential cleavage specificities of the poliovirus 3C proteinase. Nucleic Acids Res (1987) 2.77

Nucleotide and amino acid sequence coding for polypeptides of foot-and-mouth disease virus type A12. J Virol (1985) 2.65

Sequence analysis of three Sindbis virus mutants temperature-sensitive in the capsid protein autoprotease. Proc Natl Acad Sci U S A (1985) 2.18

Cleavage of the cap binding protein complex polypeptide p220 is not effected by the second poliovirus protease 2A. Virology (1986) 2.02

A chimeric plasmid from cDNA clones of poliovirus and coxsackievirus produces a recombinant virus that is temperature-sensitive. Proc Natl Acad Sci U S A (1986) 1.90

Modulation of the expression of poliovirus proteins in reticulocyte lysates. Virology (1986) 1.83

Human rhinovirus 14 infection of HeLa cells results in the proteolytic cleavage of the p220 cap-binding complex subunit and inactivates globin mRNA translation in vitro. J Virol (1985) 1.79

Proteolytic processing of foot-and-mouth disease virus polyproteins expressed in a cell-free system from clone-derived transcripts. J Virol (1987) 1.77

Shutoff of host translation by encephalomyocarditis virus infection does not involve cleavage of the eucaryotic initiation factor 4F polypeptide that accompanies poliovirus infection. J Virol (1985) 1.66

Theiler's virus genome is closely related to that of encephalomyocarditis virus, the prototype cardiovirus. J Virol (1986) 1.55

Poliovirus protease does not mediate cleavage of the 220,000-Da component of the cap binding protein complex. Proc Natl Acad Sci U S A (1985) 1.47

Restriction of translation of capped mRNA in vitro as a model for poliovirus-induced inhibition of host cell protein synthesis: relationship to p220 cleavage. J Virol (1987) 1.41

Relationship of Theiler's murine encephalomyelitis viruses to the cardiovirus genus of picornaviruses. Intervirology (1986) 1.30

Foot-and-mouth disease virion RNA: studies on the relation between the length of its 3'-poly(A) segment and infectivity. Virology (1979) 1.25

Monoclonal antibody-aided characterization of cellular p220 in uninfected and poliovirus-infected HeLa cells: subcellular distribution and identification of conformers. J Virol (1987) 1.23

Poliovirus protease 3C (P3-7c) does not cleave P220 of the eucaryotic mRNA cap-binding protein complex. J Virol (1985) 1.18

Effect of interferon, elevated temperature, and cell type on replication of acute hemorrhagic conjunctivitis viruses. Infect Immun (1977) 1.13

The effect of poliovirus infection on the translation in vitro of VSV messenger ribonucleoprotein particles. Virology (1983) 1.12

Antigenic comparison of the polypeptides of foot-and-mouth disease virus serotypes and other picornaviruses. Virology (1987) 0.97

Articles by these authors

Cloned viral protein vaccine for foot-and-mouth disease: responses in cattle and swine. Science (1981) 5.66

Translation of poliovirus RNA in vitro: changes in cleavage pattern and initiation sites by ribosomal salt wash. Virology (1979) 3.61

Membrane rearrangement and vesicle induction by recombinant poliovirus 2C and 2BC in human cells. Virology (1994) 3.52

Poly (rC) binding protein 2 forms a ternary complex with the 5'-terminal sequences of poliovirus RNA and the viral 3CD proteinase. RNA (1997) 3.47

Requirement of poly(rC) binding protein 2 for translation of poliovirus RNA. J Virol (1997) 3.40

Leader protein of foot-and-mouth disease virus is required for cleavage of the p220 component of the cap-binding protein complex. J Virol (1988) 3.28

Double-stranded poliovirus RNA inhibits initiation of protein synthesis by reticulocyte lysates. Proc Natl Acad Sci U S A (1971) 2.99

Poly(rC) binding protein 2 binds to stem-loop IV of the poliovirus RNA 5' noncoding region: identification by automated liquid chromatography-tandem mass spectrometry. Proc Natl Acad Sci U S A (1996) 2.82

Isolation of a viral polypeptide associated with poliovirus RNA polymerase. Proc Natl Acad Sci U S A (1974) 2.79

Nucleotide and amino acid sequence coding for polypeptides of foot-and-mouth disease virus type A12. J Virol (1985) 2.65

Translation of poliovirus RNA in vitro: detection of two different initiation sites. J Mol Biol (1975) 2.58

Control of protein synthesis in extracts from poliovirus-infected cells. I. mRNA discrimination by crude initiation factors. J Virol (1978) 2.31

An internal 5'-noncoding region required for translation of poliovirus RNA in vitro. J Virol (1988) 2.29

Soluble RNA polymerase complex from poliovirus-infected HeLa cells. Virology (1970) 2.26

Formation of the poliovirus replication complex requires coupled viral translation, vesicle production, and viral RNA synthesis. J Virol (2000) 2.13

Poliovirus 2C protein determinants of membrane binding and rearrangements in mammalian cells. J Virol (1997) 2.13

Adenylate-rich sequences in vesicular stomatitis virus messenger ribonucleic acid. J Virol (1972) 2.05

Cleavage of the cap binding protein complex polypeptide p220 is not effected by the second poliovirus protease 2A. Virology (1986) 2.02

Differential utilization of poly(rC) binding protein 2 in translation directed by picornavirus IRES elements. RNA (1999) 2.00

Untranslated vesicular stomatitis virus messenger RNA after poliovirus infection. Virology (1977) 1.92

Sub-cellular localization of vesicular stomatitis virus messenger RNAs. Biochem Biophys Res Commun (1975) 1.91

In vitro synthesis of proteins by membrane-bound polyribosomes from vesicular stomatitis virus-infected HeLa cells. J Virol (1974) 1.90

Demonstration in vitro that eucaryotic initiation factor 3 is active but that a cap-binding protein complex is inactive in poliovirus-infected HeLa cells. J Virol (1984) 1.87

Th size and shape of bacteria by light scattering measurements. Biochim Biophys Acta (1968) 1.85

Poliovirus-induced inhibition of host-cell protein synthesis. Cell (1982) 1.79

Poliovirus RNA replication. Curr Top Microbiol Immunol (1990) 1.78

Proteolytic processing of foot-and-mouth disease virus polyproteins expressed in a cell-free system from clone-derived transcripts. J Virol (1987) 1.77

Alterations in initiation factor activity from poliovirus-infected HeLa cells. J Biol Chem (1979) 1.75

The cap-binding protein complex in uninfected and poliovirus-infected HeLa cells. J Biol Chem (1987) 1.73

Cytoplasm from poliovirus-infected HeLa cells inhibits cell-free haemoglobin synthesis. Nat New Biol (1971) 1.72

Genetic and physiological analysis of conjugation in Streptococcus faecalis. J Bacteriol (1982) 1.72

The foot-and-mouth disease virus leader proteinase gene is not required for viral replication. J Virol (1995) 1.61

Synthesis of plus- and minus-strand RNA from poliovirion RNA template in vitro. J Virol (1986) 1.60

Eukaryotic initiation factor 3 is required for poliovirus 2A protease-induced cleavage of the p220 component of eukaryotic initiation factor 4F. Proc Natl Acad Sci U S A (1990) 1.58

Comparison of replication complexes synthesizing poliovirus RNA. Virology (1981) 1.55

The 5'-terminal nucleotides of hepatitis A virus RNA, but not poliovirus RNA, are required for infectivity. J Virol (1991) 1.55

Identification of terminal adenylyl transferase activity of the poliovirus polymerase 3Dpol. J Virol (1994) 1.52

Identification of amino acid and nucleotide sequence of the foot-and-mouth disease virus RNA polymerase. Virology (1983) 1.51

RNA duplex unwinding activity of poliovirus RNA-dependent RNA polymerase 3Dpol. J Virol (1993) 1.51

Requirements for assembly of poliovirus replication complexes and negative-strand RNA synthesis. J Virol (2001) 1.50

Purification, characterization, and comparison of poliovirus RNA polymerase from native and recombinant sources. J Biol Chem (1991) 1.49

Effects of mutations in poliovirus 3Dpol on RNA polymerase activity and on polyprotein cleavage. J Virol (1989) 1.48

Poliovirus protease does not mediate cleavage of the 220,000-Da component of the cap binding protein complex. Proc Natl Acad Sci U S A (1985) 1.47

Biochemical map of polypeptides specified by foot-and-mouth disease virus. J Virol (1984) 1.46

Translation of foot-and-mouth disease virion RNA and processing of the primary cleavage products in a rabbit reticulocyte lysate. Virology (1982) 1.44

Ability of foot-and-mouth disease virus to form plaques in cell culture is associated with suppression of alpha/beta interferon. J Virol (1999) 1.43

Identification of the active-site residues of the L proteinase of foot-and-mouth disease virus. J Virol (1995) 1.42

Restriction of translation of capped mRNA in vitro as a model for poliovirus-induced inhibition of host cell protein synthesis: relationship to p220 cleavage. J Virol (1987) 1.41

Inefficient complementation activity of poliovirus 2C and 3D proteins for rescue of lethal mutations. J Virol (1995) 1.40

Effect of poliovirus double-stranded RNA on viral and host-cell protein synthesis. Proc Natl Acad Sci U S A (1974) 1.39

Polyadenylation of vesicular stomatitis virus mRNA. J Virol (1974) 1.39

Association of cap-binding protein with eucaryotic initiation factor 3 in initiation factor preparations from uninfected and poliovirus-infected HeLa cells. J Virol (1982) 1.38

Capsid protein precursor is one of two initiated products of translation of poliovirus RNA in vitro. J Virol (1979) 1.37

Characterization of a cell culture persistently infected with the DA strain of Theiler's murine encephalomyelitis virus. J Virol (1982) 1.37

In vitro protein-synthesizing activity of vesicular stomatitis virus-infected cell extracts. J Virol (1973) 1.37

Pathogenesis of wild-type and leaderless foot-and-mouth disease virus in cattle. J Virol (1996) 1.35

trans rescue of a mutant poliovirus RNA polymerase function. J Virol (1991) 1.35

Presence of the cap-binding protein in initiation factor preparations from poliovirus-infected HeLa cells. J Virol (1981) 1.35

Specific interactions of HeLa cell proteins with proposed translation domains of the poliovirus 5' noncoding region. J Virol (1992) 1.34

Expression of the fibronectin-binding components of Streptococcus pyogenes in Escherichia coli demonstrates that they are proteins. Mol Microbiol (1991) 1.31

Viral polypeptides associated with the RNA replication complex in poliovirus-infected cells. Virology (1980) 1.31

Antiviral effects of a thiol protease inhibitor on foot-and-mouth disease virus. J Virol (1992) 1.29

Host factor-induced template modification during synthesis of poliovirus RNA in vitro. J Virol (1987) 1.29

Inhibition of L-deleted foot-and-mouth disease virus replication by alpha/beta interferon involves double-stranded RNA-dependent protein kinase. J Virol (2001) 1.28

Enzymatic activity of poliovirus RNA polymerase synthesized in Escherichia coli from viral cDNA. Virology (1988) 1.26

Inhibition of host cell protein synthesis by UV-inactivated poliovirus. J Virol (1977) 1.26

Host cell proteins binding to domain IV of the 5' noncoding region of poliovirus RNA. J Virol (1995) 1.26

Full-length viral RNA synthesized in vitro by vesicular stomatitis virus-infected HeLa cell extracts. Virology (1979) 1.26

Relationship of eukaryotic initiation factor 3 to poliovirus-induced p220 cleavage activity. J Virol (1992) 1.25

Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24. Vaccine (2002) 1.25

Foot-and-mouth disease virion RNA: studies on the relation between the length of its 3'-poly(A) segment and infectivity. Virology (1979) 1.25

Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate. Virology (1997) 1.24

Studies on the in vivo and in vitro messenger RNA species of vesicular stomatitis virus. Virology (1975) 1.23

Interaction of poly(rC) binding protein 2 with the 5' noncoding region of hepatitis A virus RNA and its effects on translation. J Virol (1998) 1.22

Analysis of a potential myristoylation site in hepatitis A virus capsid protein VP4. Virology (1993) 1.22

The structural polypeptides of aphthovirus are phosphoproteins. Proc Natl Acad Sci U S A (1980) 1.20

Formation of poliovirus RNA polymerase 3D in Escherichia coli by cleavage of fusion proteins expressed from cloned viral cDNA. Virology (1987) 1.20

Structure of poliovirus replicative intermediate RNA. Electron microscope analysis of RNA cross-linked in vivo with psoralen derivative. J Mol Biol (1984) 1.19

Sequence variation in the gene for the immunogenic capsid protein VP1 of foot-and-mouth disease virus type A. Proc Natl Acad Sci U S A (1985) 1.19

Induction of intracellular membrane rearrangements by HAV proteins 2C and 2BC. Virology (1997) 1.19

Hepatitis A virus polyprotein synthesis initiates from two alternative AUG codons. Virology (1992) 1.19

Rapid completion of the replication cycle of hepatitis A virus subsequent to reversal of guanidine inhibition. Virology (1991) 1.17

Protection of swine by live and inactivated vaccines prepared from a leader proteinase-deficient serotype A12 foot-and-mouth disease virus. Vaccine (1998) 1.16

Isolation of foot-and-mouth disease virus messenger RNA from membrane-bound polyribosomes and characterization of its 5' and 3' termini. Virology (1979) 1.16

The pathogenesis of foot-and-mouth disease II: viral pathways in swine, small ruminants, and wildlife; myotropism, chronic syndromes, and molecular virus-host interactions. Transbound Emerg Dis (2011) 1.15

Hepatitis A virus capsid protein VP1 has a heterogeneous C terminus. J Virol (1999) 1.15

Proteolytic activity of hepatitis A virus 3C protein. J Virol (1991) 1.15

Polyprotein processing in cis and in trans by hepatitis A virus 3C protease cloned and expressed in Escherichia coli. J Virol (1992) 1.14

Initiation factor preparations from poliovirus-infected cells restrict translation in reticulocyte lysates. Virology (1980) 1.13

The effect of poliovirus infection on the translation in vitro of VSV messenger ribonucleoprotein particles. Virology (1983) 1.12

Primary cleavage of the HAV capsid protein precursor in the middle of the proposed 2A coding region. Virology (1993) 1.09

Mutation of lysine residues in the nucleotide binding segments of the poliovirus RNA-dependent RNA polymerase. J Virol (1996) 1.09

Restricted replication of vesicular stomatitis virus in human lymphoblastoid cells. J Virol (1973) 1.08

Identification and characterization of messenger ribonucleoprotein complexes from vesicular stomatitis virus-infected HeLa cells. Virology (1977) 1.08

Cytoplasmic and nuclear pyrimidine ribonucleotide pools in HeLa cells. J Mol Biol (1973) 1.07

Effects of poliovirus 3AB protein on 3D polymerase-catalyzed reaction. J Biol Chem (1998) 1.06